Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology. (Q47983600)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Middle-Aged Diabetic Females and Males Present Distinct Susceptibility to Alzheimer Disease-like Pathology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Cristina Carvalho

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Sónia C. Correia

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Raquel Seiça

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Catarina R. Oliveira

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Paula I. Moreira

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Ana I Plácido

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

E Candeias

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

I Sebastião

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

M A Fernandes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

R X Santos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

M S Santos

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

11 October 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

6471-6489

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants

25 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

The growing prevalence of type 2 diabetes: increased incidence or improved survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

The central question of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Insulin in central nervous system: more than just a peripheral hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Vascular, oxidative, and synaptosomal abnormalities during aging and the progression of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Encephalopathies: the emerging diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Insulin-resistant brain state: the culprit in sporadic Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Estrogen: a master regulator of bioenergetic systems in the brain and body

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Crosstalk between diabetes and brain: glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden--a model explaining the diabetes epidemic worldwide today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Gender-specific epidemiology of diabetes: a representative cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Timing of Estradiol Treatment After Menopause May Determine Benefit or Harm to Insulin Action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Sex differences in type 2 diabetes: focus on disease course and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Alzheimer's disease, dementia, mild cognitive impairment and the menopause: a 'window of opportunity'?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Risk of Alzheimer's disease in relation to diabetes: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Type 2 diabetes affects hippocampus volume differentially in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Female exhibited severe cognitive impairment in type 2 diabetes mellitus mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

New evidence of mitochondria dysfunction in the female Alzheimer's disease brain: deficiency of estrogen receptor-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Aging and ovariectomy cause a decrease in brain glucose consumption in vivo in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Estrogen and Cognitive Functioning in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Gender, sex steroid hormones, and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Transcriptome meta-analysis reveals a central role for sex steroids in the degeneration of hippocampal neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

17β-Estradiol and genistein acute treatments improve some cerebral cortex homeostasis aspects deteriorated by aging in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Acute effects of 17 β-estradiol and genistein on insulin sensitivity and spatial memory in aged ovariectomized female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Dehydroepiandrosterone prevents the aggregation of platelets obtained from postmenopausal women with type 2 diabetes mellitus through the activation of the PKC/eNOS/NO pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Dehydroepiandrosterone modulates nuclear factor-kappaB activation in hippocampus of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Amyloid precursor protein mutation disrupts reproductive experience-enhanced normal cognitive development in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Hippocampal morphology is differentially affected by reproductive experience in the mother.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Maternal experience produces long-lasting behavioral modifications in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Motherhood improves learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Mitochondrial quality control systems sustain brain mitochondrial bioenergetics in early stages of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Oxidative stress affects synaptosomal gamma-aminobutyric acid and glutamate transport in diabetic rats: the role of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Synaptosomes isolated from Goto-Kakizaki diabetic rat brain exhibit increased resistance to oxidative stress: role of vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Diabetic Goto-Kakizaki rats display pronounced hyperglycemia and longer-lasting cognitive impairments following ischemia induced by cortical compression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Diabetic type II Goto-Kakizaki rats show progressively decreasing exploratory activity and learning impairments in fixed and progressive ratios of a lever-press task

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Insulin protects against amyloid beta-peptide toxicity in brain mitochondria of diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Early reproductive experiences in females make differences in cognitive function later in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Neurosteroid biosynthesis and action during cerebellar development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Neurosteroids: biochemistry and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Chronic estradiol treatment improves brain homeostasis during aging in female rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Oestrogen receptor alpha localisation in the prefrontal cortex of three mammalian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

17β-Estradiol regulates insulin-degrading enzyme expression via an ERβ/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Interactions of estrogen and insulin-like growth factor-I in the brain: molecular mechanisms and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Synergistic interaction of estradiol and insulin-like growth factor-I in the activation of PI3K/Akt signaling in the adult rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Brain atrophy in type 2 diabetes: regional distribution and influence on cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Insulin resistance and pathological brain ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Cross-talk between IGF-I and estradiol in the brain: focus on neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Post-translational modifications of tau protein: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Tau phosphorylation in neuronal cell function and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Associations between sex hormones and cognitive and neuropsychiatric manifestations in vascular dementia (VaD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Sex differences in β-amyloid accumulation in 3xTg-AD mice: role of neonatal sex steroid hormone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Type 2 diabetes - a matter of failing beta-cell neogenesis? Clues from the GK rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Differential changes of aorta and carotid vasodilation in type 2 diabetic GK and OLETF rats: paradoxical roles of hyperglycemia and insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Proinsulin processing in the diabetic Goto-Kakizaki rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Enhanced Glucose Tolerance and Pancreatic Beta Cell Function by Low Dose Aspirin in Hyperglycemic Insulin-Resistant Type 2 Diabetic Goto-Kakizaki (GK) Rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Effects of palmitate on insulin secretion and exocytotic proteins in islets of diabetic Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Is brain estradiol a hormone or a neurotransmitter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Neurosteroid synthesis in the hippocampus: role in synaptic plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Para/autocrine regulation of estrogen receptors in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Influence of aging and menopause on lipids and lipoproteins in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Neurosteroids as regenerative agents in the brain: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Steroids as γ-secretase modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Statins for the prevention of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Cholesterol in Alzheimer's disease: unresolved questions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Midlife cardiovascular risk factors and risk of dementia in late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

The 32-year relationship between cholesterol and dementia from midlife to late life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

High total cholesterol levels in late life associated with a reduced risk of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Cholesterol balance in prion diseases and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Oxysterols, cholesterol homeostasis, and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Estrogen and aging affect the synaptic distribution of estrogen receptor beta-immunoreactivity in the CA1 region of female rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Estrogen receptor polymorphisms and incident dementia: the prospective 3C study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Decreased alternative splicing of estrogen receptor-α mRNA in the Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Estrogen receptors: how do they signal and what are their targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Estrogen receptor beta in the brain: from form to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Estrogen receptor-beta mRNA variants in human and murine tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Serum insulin-like growth factor I regulates brain amyloid-beta levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Obesity-induced diabetes (diabesity) in C57BL/KsJ mice produces aberrant trans-regulation of sex steroid sulfotransferase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Tau is hyperphosphorylated at multiple sites in mouse brain in vivo after streptozotocin-induced insulin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Mitochondrial oxidant generation is involved in determining why females live longer than males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Why females live longer than males: control of longevity by sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Endogenous oestrogens predict 4-year decline in verbal fluency in postmenopausal women: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Life long endogenous estrogen exposure and later adulthood cognitive function in a population of naturally postmenopausal women from Southern China: the Guangzhou Biobank Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

The number of pregnancies is a risk factor for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Fertility and number of children in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Cognition in pregnancy and motherhood: prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Multiparity-induced enhancement of hippocampal neurogenesis and spatial memory depends on ovarian hormone status in middle age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Diabetes mellitus as a modulator of functional impairment and decline in Alzheimer's disease. The Real.FR cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Identification of a splice variant of the rat estrogen receptor β gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-016-0155-1

Amyloid beta oligomers induce impairment of neuronal insulin receptors

21 January 2018

1 reference

12 December 2020

Estrogen actions in the central nervous system

1 reference

12 December 2020

Parity, number of pregnancies, and the age of onset of Alzheimer's disease.

1 reference

12 December 2020

Metabolic inflammation exacerbates dopaminergic neuronal degeneration in response to acute MPTP challenge in type 2 diabetes mice

1 reference

12 December 2020

Hypothalamic alterations and reproductive aging in female rats: evidence of altered luteinizing hormone-releasing hormone neuronal function

1 reference

12 December 2020

Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates τ Protein Phosphorylated by Proline‐Directed Protein Kinases or Cyclic AMP‐Dependent Protein Kinase

1 reference

12 December 2020

Pathophysiological and genetic characterization of the major diabetes locus in GK rats

1 reference

12 December 2020

Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease.

1 reference

12 December 2020

Early reduction of circulating homocysteine levels in Goto–Kakizaki rat, a spontaneous nonobese model of type 2 diabetes

1 reference

12 December 2020

Cross-coupling between insulin and estrogen receptor in human neuroblastoma cells

1 reference

12 December 2020

Evaluation of neuroactive steroid levels by liquid chromatography–tandem mass spectrometry in central and peripheral nervous system: Effect of diabetes

1 reference

12 December 2020

Preventing Alzheimer's disease and cognitive decline

1 reference

12 December 2020

Antioxidant and vascular effects of gliclazide in type 2 diabetic rats fed high-fat diet

1 reference

12 December 2020

Evidence for cortical neuronal loss in male type 2 diabetic Goto-Kakizaki rats

1 reference

12 December 2020

Effect of transdermal testosterone or alpha-lipoic acid on erectile dysfunction and quality of life in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Glia-neuron crosstalk in the neuroprotective mechanisms of sex steroid hormones

1 reference

12 December 2020

10.1007/S12035-016-0155-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27730513%20AND%20SRC:MED&resulttype=core&format=json

release_22aslkajxvhm3heepqga5yn26a

25 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/22aslkajxvhm3heepqga5yn26a

24 November 2022

mapped directly with Wikidata item

1 reference